ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
Overview | Financials
Company Name | ACADIA Pharmaceuticals Inc. |
Symbol | ACAD |
Currency | USD |
Price | 16.9 |
Market Cap | 2,812,024,800 |
Dividend Yield | 0% |
52-week-range | 14.15 - 29.29 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Stephen R. Davis J.D. |
Website | https://www.acadia-pharm.com |
An error occurred while fetching data.
About ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD